22840-5618 : Fusarium Moniliforme .05 g/ml Intradermal; Percutaneous; Subcutaneous Solution


NDC22840-5618
Labeler: Greer Laboratories, Inc.
Product Type: Non-standardized Allergenic
Drug Name: Fusarium Moniliforme
Dosage Form: Intradermal; Percutaneous; Subcutaneous Solution
Application #: BLA101833
Rev. Date: 


NDC Package Codes:

  • 22840-5618-2: 10 ML IN 1 VIAL, MULTI‑DOSE (22840‑5618‑2)
  • 22840-5618-4: 50 ML IN 1 VIAL, MULTI‑DOSE (22840‑5618‑4)
  • 22840-5618-5: 5 ML IN 1 BOTTLE, DROPPER (22840‑5618‑5)

Active Ingredients:

  • Gibberella Fujikuroi

Dosage Strength:

  • .05 g/mL

Pharmaceutical Classes:

  • Allergens [CS]
  • Cell-mediated Immunity [PE]
  • Fungal Proteins [CS]
  • Increased Histamine Release [PE]
  • Increased IgG Production [PE]
  • Non-Standardized Fungal Allergenic Extract [EPC]

Related Products:

Based on records with the same trade name.
  • 22840-1670 Fusarium Moniliforme .1 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
  • 22840-1671 Fusarium Moniliforme 20000 [Pnu]/Ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
  • 22840-1672 Fusarium Moniliforme .05 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
  • 22840-1673 Fusarium Moniliforme 40000 [Pnu]/Ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.
  • 22840-1674 Fusarium Moniliforme .001 g/ml Intradermal; Percutaneous; Subcutaneous Solution by Greer Laboratories, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 22840-5618 QR Code

< Prev: 22840-5617Next: 22840-5619 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.